+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Suzuken Co Ltd (9987) - Financial and Strategic SWOT Analysis Review

  • ID: 4284655
  • SWOT Analysis
  • 36 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4


  • Alfresa Holdings Corp
  • Astellas Pharma Inc
  • Kyowa Hakko Kirin Co Ltd
  • Sumitomo Chemical Co Ltd
  • MORE
Suzuken Co Ltd (9987) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Suzuken Co Ltd (Suzuken) is a distributor of pharmaceuticals, diagnostic regents, medical equipment and supplies, and medical foods. It develops and manufactures sphygmomanometers, electrocardiographs (ECGs), other medical equipment, and diagnostic products and pharmaceuticals for diabetes and kidney diseases. The company conducts research to advance its pipeline products for the treatment of constipation, renal anemia, hyperparathyroid, nocturia, pruritus, and type 2 diabetes. Suzuken also provides nursing care; manufacturer support services including contract distribution services and distribution of orphan drugs; and training and education for local insurance pharmacies. The company serves hospitals, clinics, insurance pharmacies, pharmaceutical companies, and medical institutions in Japan. Suzuken is headquartered in Nagoya, Aichi Prefecture, Japan.

Key Benefits

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4


  • Alfresa Holdings Corp
  • Astellas Pharma Inc
  • Kyowa Hakko Kirin Co Ltd
  • Sumitomo Chemical Co Ltd
  • MORE
Section 1 - About the Company
  • Suzuken Co Ltd - Key Facts
  • Suzuken Co Ltd - Key Employees
  • Suzuken Co Ltd - Key Employee Biographies
  • Suzuken Co Ltd - Major Products and Services
  • Suzuken Co Ltd - History
  • Suzuken Co Ltd - Company Statement
  • Suzuken Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Suzuken Co Ltd - Business Description
  • Business Segment: Healthcare-Related Services
  • Overview
  • Performance
  • Business Segment: Insurance Pharmacy
  • Overview
  • Performance
  • Business Segment: Intersegment Elimination
  • Performance
  • Business Segment: Pharmaceutical Distribution Business
  • Overview
  • Performance
  • Business Segment: Pharmaceutical Manufacturing
  • Overview
  • Performance
  • R&D Overview
  • Suzuken Co Ltd - Corporate Strategy
  • Suzuken Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Suzuken Co Ltd - Strengths
  • Suzuken Co Ltd - Weaknesses
  • Suzuken Co Ltd - Opportunities
  • Suzuken Co Ltd - Threats
  • Suzuken Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Suzuken Co Ltd, Recent Deals Summary
Section 4 – Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Disclaimer
List of Tables
  • Suzuken Co Ltd, Key Facts
  • Suzuken Co Ltd, Key Employees
  • Suzuken Co Ltd, Key Employee Biographies
  • Suzuken Co Ltd, Major Products and Services
  • Suzuken Co Ltd, History
  • Suzuken Co Ltd, Subsidiaries
  • Suzuken Co Ltd, Key Competitors
  • Suzuken Co Ltd, Ratios based on current share price
  • Suzuken Co Ltd, Annual Ratios
  • Suzuken Co Ltd, Interim Ratios
  • Suzuken Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Suzuken Co Ltd, Performance Chart (2014 - 2018)
  • Suzuken Co Ltd, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Taisho Pharmaceutical Holdings Co Ltd
  • Sumitomo Chemical Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Astellas Pharma Inc
  • Alfresa Holdings Corp
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4284655